Mylan Inc.
NASDAQ: MYL
$15.86
+$0.00 (+0.0%)
Closing Price on November 19, 2020
MYL Articles
The FDA is extending the expiration dates for certain EpiPens in light of the national shortage ahead of the back-to-school season.
Published:
Last Updated:
Mylan has had a stranglehold on the market for EpiPen, but this is all changing after the FDA approved Teva for a generic version of it.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday included Akamai, Dollar Tree, Hasbro, Intel, Mylan, Netflix and Papa John's.
Published:
Last Updated:
24/7 Wall St. tracked six companies that saw three or more analyst downgrades or price target cuts on Thursday, August 9, 2018.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Applied Materials, Extreme Networks, Mylan, NXP, Roku, Seagate, Yelp and Zynga.
Published:
Last Updated:
Mylan reported disappointing quarterly results before the markets opened on Wednesday, and shares retreated afterward.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Disney, Snap, CVS Health and some of the other companies that are about to report their quarterly results.
Published:
Last Updated:
Adamis Pharmaceuticals saw its shares shoot up early on Monday after the firm announced a partnership with a subsidiary of Novartis.
Published:
Last Updated:
Thursday was a positive day for the broad U.S. markets. Again, the Nasdaq hit an all-time high in the session reaching closer to 7,800. The S&P 500 is still holding just below the 2,800 mark....
Published:
Last Updated:
Mylan saw its shares make a handy gain early on Tuesday after the FDA announced a key approval for Fulphila (pegfilgrastim-jmbd), a biosimilar to Neulasta (pegfilgrastim).
Published:
Last Updated:
24/7 Wall St. has put together a preview of Disney, Nvidia, Valeant Pharmaceuticals and of some of the other top companies reporting their latest results in the coming week.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Albermarle, American Airlines, Ellie Mae, Johnson & Johnson, Mallinckrodt, Mylan, NetApp and Southwest Airlines.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include AON, Broadcom, Expedia, Exxon Mobil, Match, Mylan, Ocean Rig UDW, Signet Jewelers and Transocean.
Published:
Last Updated:
Mylan has been through the ringer over the past couple of years, but by the looks of it, this stock could be turning around.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include Archer Daniels Midland, Cardlytics, Dermira, E*Trade, Herbalife, Mylan, UPS, VMware and Western Digital.
Published:
Last Updated: